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 24 
Abstract 25 
Background: Mastitis is the most prevalent disease in dairy sheep with major economic, 26 
hygienic and welfare implications. The disease persists in all dairy sheep production systems 27 
despite the implementation of improved management practises. Selective breeding for 28 
enhanced mastitis resistance may provide the means to further control the disease. In the 29 
present study, we investigated the genetic architecture of four mastitis traits in dairy sheep. 30 
Individual animal records for clinical mastitis occurrence and three mastitis indicator traits 31 
(milk somatic cell count, total viable bacterial count in milk and the California mastitis test) 32 
were collected monthly throughout lactation for 609 ewes of the Greek Chios breed. All 33 
animals were genotyped with a custom-made 960-single nucleotide polymorphism (SNP) 34 
DNA array based on markers located in quantitative trait loci (QTL) regions for mastitis 35 
resistance previously detected in three other distinct dairy sheep populations.    36 
Results: Heritable variation and strong positive genetic correlations were estimated for 37 
clinical mastitis occurrence and the three mastitis indicator traits. SNP markers significantly 38 
associated with these mastitis traits were confirmed on chromosomes 2, 3, 5, 16 and 19. We 39 
identified pathways, molecular interaction networks and functional gene clusters for mastitis 40 
resistance. Candidate genes within the detected regions were identified based upon analysis 41 
of an ovine transcriptional atlas and transcriptome data derived from milk somatic cells. 42 
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Relevant candidate genes implicated in innate immunity included SOCS2, CTLA4, C6, C7, 43 
C9, PTGER4, DAB2, CARD6, OSMR, PLXNC1, IDH1, ICOS, FYB, and LYFR.   44 
Conclusions: The results confirmed the presence of animal genetic variability in mastitis 45 
resistance and identified genomic regions associated with specific mastitis traits in the Chios 46 
sheep. The conserved genetic architecture of mastitis resistance between distinct dairy sheep 47 
breeds suggests that across-breed selection programmes would be feasible. 48 
Keywords: genomic association; sheep transcriptomic atlas; milk transcriptome; 49 
transcription factor binding sites; mastitis; somatic cell count; total viable bacterial 50 
count; California mastitis test; Chios sheep; dairy sheep  51 
 52 
Background 53 
Mastitis is an inflammation of the mammary gland usually caused by pathogens, mainly 54 
bacteria, developed in the gland cistern after penetration through the teat canal. It is the most 55 
prevalent and costly disease in the dairy industry due to reduced and discarded milk, early 56 
involuntary culling, veterinary service and labour costs [1, 2]. There is also the possibility for 57 
the spread of a zoonotic disease as well as the development of microbial resistance to 58 
antibiotics [1, 2[3]]. Mastitis compromises animal welfare causing pain, anxiety, restlessness 59 
and changes in feeding behaviour [4]. The issue of mastitis is a central element in the design 60 
and implementation of management schemes in dairy sheep farms. The notion is that for 61 
every case of confirmed clinical mastitis there are at least 40 other animals in the flock with 62 
subclinical mastitis. Reviews of management practices and practical approaches to control 63 
sheep mastitis have been published [5, 6]. 64 
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The susceptibility of dairy animals to udder infection is heritable [2, 7-9] but the 65 
current knowledge of the complex physiological and cellular events that occur in the 66 
mammary gland in response to pathogens is limited. In cattle, the common mastitis 67 
pathogens, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), activate the 68 
mammary immune system in different ways, influencing disease severity and chronicity [10]. 69 
The recruitment of leukocytes (neutrophils) in the udder in response to infection is measured 70 
as the milk somatic cell count (SCC) [11].  Breeding programmes based on animal pedigrees 71 
and SCC records (as a correlated trait for mastitis) have been implemented in dairy cattle 72 
worldwide [12] as well as the French Lacaune dairy sheep [13, 14]. Marker assisted selection 73 
or genomic selection based on genotyping of single nucleotide polymorphism (SNP) markers 74 
could enhance and expedite the efforts for genetic improvement. 75 
Quantitative trait loci (QTLs) and SNPs associated with SCC have been previously 76 
identified based on linkage and linkage disequilibrium analyses of three distinct dairy sheep 77 
breeds (French Lacaune, Spanish Churra and Italian Sarda [15-19]). Several QTLs were 78 
common (i.e. located within 2 Mb regions) to two or more breeds in these studies. A custom-79 
made 960-SNP DNA array for ovine mastitis resistance containing markers on six 80 
chromosomes (2, 3, 5, 12, 16 and 19) was then developed. The array was based on the 81 
common QTLs among breeds and some additional well-defined (i.e. confidence interval less 82 
than 0.5 Mb) QTL regions with large effects, as well as further genotyping with the Illumina 83 
OvineSNP800 Bead chip and re-sequencing of selected QTL regions (Additional File 1: 84 
Table S1) within an FP7 European funded project 85 
(http://cordis.europa.eu/result/rcn/163471_en.html). For the design of the custom-made array, 86 
SNPs were selected from both the 50K and the 800K SNP DNA arrays, as well as the 87 
available re-sequencing data; the array had an average density of 1 SNP every 23 Kb. The 88 
present study builds on results from previous studies on Lacaune, Churra and Sarda sheep 89 
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[15-19] in order to dissect the genomic architecture of mastitis resistance in an independent 90 
sheep population, the Greek Chios breed. Genotyping was performed with the 91 
aforementioned mastitis-specific custom-made DNA array. We conducted variance 92 
component analyses to estimate genetic parameters and genomic association studies to 93 
identify genomic regions controlling mastitis. We also performed pathway analysis and 94 
examined gene expression and transcription factor binding site data to identify candidate 95 
genes within the relevant genomic regions. 96 
Results 97 
Principal component analysis 98 
French Lacaune, Spanish Churra, Italian Sarda and Greek Chios were among the sheep 99 
breeds analysed within the framework of the sheep HapMap project [20]. Principal 100 
component analysis (PCA) was performed to examine the relatedness among these dairy 101 
breeds using genotypes obtained with the Illumina OvineSNP50 Beadchip within the 102 
HapMap project. According to the results, the four dairy breeds are genetically distinct with 103 
the first and second PCA clusters explaining 14.4% and 9.9% of the variance, respectively 104 
(Additional File 2: Figure S1). Chios is equally distant from any one of the other three breeds, 105 
with an average pairwise genetic distance (Dst) of 0.33, confirming its independent population 106 
status for the purposes of the present study.  107 
Descriptive statistics of phenotypes 108 
Descriptive statistics for SCC, California mastitis test (CMT) and total viable bacterial count 109 
in milk (TVC) are listed in Additional File 3: Table S2. The average frequency of clinical 110 
mastitis occurrence (CM) was 5.1% in our studied population. Gram positive (58% 111 
Coagulase negative Staphylococci, 22% S. aureus and 7.7% Streptococcus spp) bacteria were 112 
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mainly responsible for CM. Nevertheless, Gram negative bacteria (9.3% Pasteurella spp. and 113 
3% Proteus) were also isolated from the milk samples. Smoothed curves illustrating 114 
progression for each trait throughout lactation, after adjusting for all relevant sources of 115 
systematic variation, are shown in Fig. 1. These curves were based on second order 116 
polynomial functions of time (week of lactation) fitted in mixed model analyses of the 117 
studied traits. Higher order polynomials did not improve the model fit as attested to by the 118 
Wald statistic. As expected, values of SCC and CMT generally increased as lactation 119 
progressed [21]. TVC and CM values first showed a relative decrease until week 11 of 120 
lactation and then started gradually increasing. 121 
Genetic parameters 122 
Estimates of heritability and repeatability of the studied traits (Table 1) based on monthly 123 
records were derived for the entire lactation as well as different stages of lactation defined as 124 
early (weeks of lactation 1-7), mid (weeks 8-17) and late (weeks 18-23). Because of the 125 
binary nature of CM, only overall lactation heritability and repeatability estimates were 126 
possible to derive for this trait. Low to moderate heritabilities (0.09-0.18) were estimated for 127 
all the mastitis traits; higher heritability estimates were observed in all cases toward the end 128 
of lactation. Moreover, the genetic correlations between the different lactation stages were 129 
positive for all studied traits (Additional File 4: Table S3).  However, the genetic correlations 130 
between early and late lactation were low to moderate (0.26-0.56) suggesting that somewhat 131 
distinct genetic mechanisms may control mastitis resistance at different lactation stages. The 132 
three mastitis indicator traits (SCC, TVC and CMT) were correlated, both phenotypically and 133 
genetically, with each other and with CM, suggesting that any of the three indirect mastitis 134 
traits would be a useful predictor of CM. The genetic and phenotypic correlation estimates 135 
between traits are presented in Table 2. 136 
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Genomic association studies  137 
Genomic association studies were conducted separately for early, mid, late and overall 138 
lactation for each trait. Multidimensional scaling analysis (MDS) revealed no substructure in 139 
the Chios population In general, similar genomic associations were detected for CM and the 140 
three mastitis indicator traits but distinct associations were observed in the different lactation 141 
stages. SNPs significantly associated with the studied mastitis traits are shown in Table 3. 142 
Five (four at genome-wide and one at suggestive genome-wide significant level) of the seven 143 
QTLs previously identified in other dairy breeds were verified in the independent Chios 144 
population (Additional File 1: Table S1). Q-Q plots supported the genomic analyses results. 145 
Manhattan plots displaying these association results are shown in Fig. 2; the corresponding 146 
Q-Q plots are shown in Additional File 5: Figure S2. 147 
All significant SNP markers that were identified in the genomic association study had 148 
also a significant effect on the corresponding mastitis traits in the ensuing mixed model 149 
analyses based on the pedigree genetic relationship matrix among animals. The additive and 150 
dominance genetic effects, and the proportion of the total genetic and phenotypic variance 151 
explained by each of these SNPs, are summarised in Table 3. Individual significant SNP 152 
markers explained up to 27%, 39%, 33% and 39% of the genetic variance of CMT, SCC, 153 
TVC and CM, respectively. The significant markers corresponding to the same QTL were in 154 
linkage disequilibrium (LD as r
2
=0.20-0.97), implying that they likely correspond to the same 155 
causative variation (Additional File 6: Table S4). Only small LD blocks (less than 200 kb 156 
length) were visualised with Haploview, probably due to a high number of recombination 157 
events having taken place in the outbred Chios population (Additional File 7: Figure S3). The 158 
significant markers were located in close proximity to each other, with most of them being 159 
inside neighbouring small LD blocks, and spanned the previously identified QTL regions in 160 
Lacaune, Churra and Sarda (Additional File 7: Figure S3). 161 
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Annotation of SNP markers and QTL candidate regions  162 
A relatively small number of genes (53 protein-coding and 26 microRNAs) were identified in 163 
the candidate regions for mastitis resistance (Additional File 8: Table S5). All significant 164 
SNP markers, with two exceptions, were located in intergenic or intronic regions. The  165 
exceptions were two SNPs associated significantly with TVC (oar3_OAR2_209240636) and 166 
SCC (Oar3_Oar2_208650955) in late lactation, which correspond to a missense variant in the 167 
exonic region of an enzyme of the citric acid cycle (isocitrate dehydrogenase 1, IDH1)  and to 168 
a non-coding lincRNA variant, respectively. Annotations of all significant SNP markers for 169 
CM, SCC, CMT and TVC, are presented in Additional File 9: Table S6. 170 
Pathway and functional clustering analysis 171 
Based upon the significant heritability estimates and the large amount of genetic variance 172 
accounted for by the identified SNPs, we reasoned that the corresponding QTL regions would 173 
contain genes contributing to a common pathway associated with mastitis resistance. We 174 
therefore identified the sets of annotated genes lying within QTL intervals and sought 175 
evidence of gene set enrichment. These genes were enriched for pathways involved in 176 
inflammatory and immune responses, both innate and adaptive (Fig. 3A). Moreover, two 177 
networks of molecular interactions related to immunological diseases were constructed using 178 
the list of genes in the candidate regions (Fig. 3B). We further extracted the gene ontology 179 
(GO) terms for each of the genes and performed functional annotation clustering analysis. 180 
These genes were organised into 18 clusters, each given an enrichment score (ES) 181 
(Additional File 10: Table S7). The first (ES=2.33) and the third (ES=1.53) clusters were 182 
related to the regulation of apoptosis, and to innate and adaptive immune responses involving 183 
the same immune genes identified with the pathway and network analyses (C6, C8, C9, 184 
CD28, OSMR, SOCS2, CREB1, ICOS, CTLA4, NRP2, PRPKAA1, DAB2, LIFR, PTGER4, 185 
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UBE2N, IDH1). 186 
Gene expression analysis 187 
Genes that contribute to mastitis resistance are likely to be expressed in milk somatic cells, in 188 
other immune cells, and/or in the mammary gland, and much of the genetic variation is likely 189 
to affect their transcriptional regulation. In humans, more than 80% of genes that are induced 190 
in stimulated monocytes have shown evidence of heritable variation in their level of 191 
expression (eQTL) [22].  To assess the expression profiles of genes located in the candidate 192 
regions for mastitis resistance, we obtained data from an ovine transcriptional atlas currently 193 
under development at the Roslin Institute, which is based upon the large-scale mRNA 194 
sequencing of multiple tissues and cell lines [23]; this development builds upon similar 195 
initiatives in other species [24],[25]. We also used data from an RNA-seq characterisation of 196 
the milk transcriptome of two Spanish dairy sheep breeds, Churra and Assaf, where milk 197 
somatic cells had been sampled at 10, 50, 120 and 150 days after lambing [26, 27]. A 198 
previous study identified genes involved in response to bacterial lipopolysaccharide (LPS), 199 
the major component of the outer membrane of Gram-negative bacteria, in a mouse 200 
mammary gland model of mastitis [28]. A similar model of mastitis has also been 201 
implemented in dairy cattle [29-31]. We reasoned that genes involved in mastitis 202 
susceptibility would likely be constitutively expressed in the mammary gland and immune 203 
tissues and/or differentially expressed in sheep bone marrow-derived macrophages (BMDMs) 204 
in response to LPS treatment. Both sources have been extensively analysed in the sheep atlas. 205 
In addition, we reasoned that these genes would be differentially expressed in sheep with 206 
high, intermediate and low SCC and/or their expression levels would correlate with SCC 207 
[32]. The sheep used in the milk transcriptomic study had also been phenotyped for SCC and 208 
milk yield [26, 27]. 209 
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Among all the genes located in the candidate regions for mastitis resistance identified 210 
in the present study, several (DAB2, IDH1, NDUFS1, MRPL42, FYB, SOCS2, OSMR, 211 
RGMB, PPP4R2, EGFLAM  and NUDT4) were highly expressed in both mammary gland and  212 
various immune cell lines as shown in Additional File 11: Figure S4. These genes, along with 213 
others (CTLA4, CCNYL1, CEP83, CHD1, TTC33, METTL21A, PLXNC1, CARD6, 214 
FASTKD2, PRKAA1 and PTGER4) were also inducible by LPS in sheep BMDMs (Fig. 4A 215 
and 4B).  216 
Moreover, the expression of CCNYL1, IDH1, SOCS2, MRPL42, C9, NDUFS1 and NUDT4 217 
was relatively higher than other genes in the milk transcriptome (Additional File 12: Figure 218 
S5). Some of the LPS-inducible genes (SOCS2, CARD6, C9, METTL21A and TTC33) were 219 
differentially expressed in the milk somatic cells of sheep with divergent levels of SCC (high, 220 
intermediate, low; Fig. 5). Furthermore, the level of expression of OSMR, METTL21A, 221 
CEP83, CHD1, PLXNC1, GPATCH2, ICOS, PTGER4, CARD6 and LIFR were significantly 222 
associated with SCC, but not with milk yield levels, in the Churra and Assaf sheep.  223 
Transcription factor binding site (TFBS) analysis 224 
Selective breeding in dairy sheep has led to the development of selective sweeps associated 225 
with milk production traits that are common to different breeds [33]. The apparent 226 
commonality of QTL regions affecting mastitis amongst disparate dairy breeds suggest that 227 
they may also share specific variants that confer this phenotype. There are currently 228 
insufficient whole genome sequences available to identify such variants on a population-229 
wide basis. Nevertheless, we examined the available genomes of six meat sheep (Scottish 230 
Blackface x Texel; BFxT), the cross used to create the transcriptomic atlas, and six dairy 231 
sheep sequenced as part of the Sheep HapMap project [15] (two of each Churra, Sakiz and 232 
Lacaune breed). There is no publicly available Chios genome, but the genetically similar 233 
East Aegean Sakiz breed [20] was considered as a proxy in the present study. To focus on 234 
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likely functional elements, we identified candidate TBFS within 1kb of the annotated 235 
transcription start site [34]. MATCH analysis [35] revealed similar TFBS profiles between 236 
dairy and meat sheep in the majority (62%) of the genes located in the candidate regions for 237 
mastitis resistance. For the remaining genes, distinct TFBS profiles may be attributed to 238 
differences among individual animals rather than breed type (Additional File 13: Table S8). 239 
Most of these latter genes (CHD1, PRKAA1, TTC33, CARD6, DAB2, FYB, OSMR, PPP4R2, 240 
C6, C9, PTGER4 and LIFR) were also differentially expressed in BMDMs after LPS 241 
treatment and/or in sheep with differing SCC. In general, no systematic differences were 242 
observed in TFBS profiles between dairy and meat sheep except for the following: (1) 243 
Mat1-Mc and AP-1 binding sites upstream of the OSMR and PDZRN3 genes, respectively, 244 
only in dairy sheep; (2) an HNF-1 binding site upstream of DAB2, only in meat sheep; and 245 
(3) HSF and c-Rel sites upstream of C9, only in meat and dairy sheep, respectively. 246 
Selection of candidate genes 247 
Based on all above results, a total of 14 genes were selected as the most promising candidate 248 
genes for mastitis resistance (Table 4) in the present study. Genes were selected using a 249 
combination of their known biological function, involvement in immune response pathways 250 
and networks, differential expression or enrichment in tissues relevant to mastitis, differences 251 
in TFBS, association of their expression levels with SCC and/or any previously known 252 
association with mastitis resistance in either dairy sheep or dairy cattle. 253 
 254 
Discussion  255 
The present study investigated the genomic architecture of mastitis resistance in Chios dairy 256 
sheep and assessed the utility of relevant genomic data in genetic improvement. Five QTLs 257 
located on chromosomes 2, 3, 5, 16 and 19 that had been previously identified in three 258 
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unrelated dairy sheep populations in France, Spain and Italy were found to be segregating in 259 
an independent Greek sheep breed, suggesting that genetic variation may persist in diverse 260 
populations and that joint genomic selection programmes for enhanced mastitis resistance 261 
across breeds are, in principle, feasible. The high proportion of genetic variance explained by 262 
the five common QTL regions renders this mastitis-specific 960SNP-array a useful tool in 263 
dairy sheep breeding and genetic improvement. 264 
The significance of the QTL regions reported in the present study is supported by results 265 
of a previous selection mapping study that compared dairy with meat sheep breeds to identify 266 
genomic regions under selection [33]. In the latter study, multiple pairs of dairy versus meat 267 
sheep breeds were investigated. For two specific pairs a selection signal was identified in the 268 
QTL region for mastitis resistance on chromosome 16 reported in the present study; for 269 
another pair, a selection signal was also identified close to our QTL regions on chromosomes 270 
2, 3 and 19. The consistency of these selective sweep signals with the QTLs verified in the 271 
present study attest to the significance and suitability of the genomic regions included in the 272 
custom-made 960SNP array for dairy sheep populations. 273 
Substantial genetic variance was detected in all mastitis traits of our study. Nevertheless, 274 
our findings corroborate the notion that mastitis resistance is under mostly polygenic genetic 275 
control [7, 16, 36], since 60-70% of the genetic variance remained unexplained by the 276 
identified QTLs. Previous genetic studies on other breeds, reviewed by Bishop et al. [2], 277 
reported similar heritabilities ranging from 0.10 to 0.20 for SCC. Significant positive 278 
phenotypic and genetic correlations were detected between the CM occurrence and the three 279 
mastitis indicator traits (SCC, CMT and TVC) implying some common underlying 280 
mechanisms of resistance between acute clinical episodes and persistent intra-mammary 281 
inflammations. Similar correlations between CM and SCC have been reported in the Lacaune 282 
dairy sheep [32, 37] and cattle [38]. These results confirm the utility of the indirect mastitis 283 
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measures as predictors of CM in genetic improvement programmes as well as on-farm 284 
management practices. Furthermore, the three mastitis indicator traits in the present study 285 
appeared to be under generally similar genetic mechanisms of control. Considering that the 286 
average incidence of clinical mastitis in a well-managed flock is about 2-3% and the 287 
incidence of subclinical mastitis is much higher, the use of indicator traits associated with the 288 
latter would facilitate breeding programmes achieving improvements in both subclinical and 289 
clinical mastitis resistance.  CMT and TVC were studied for the first time as phenotypes for 290 
breeding purposes. Implementation of CMT would constitute a useful tool to phenotype 291 
mastitis resistance on the farm without requiring any special equipment. 292 
In Lacaune sheep, a previous transcriptomic study of SCC associated 7 genes – cytotoxic 293 
T lymphocyte-associated protein 4 (CTLA4), suppressor of cytokine signalling 2 (SOCS2), 294 
oncostatin M receptor (OSMR), FYN oncogene related to SRC (FYN), complement factor B 295 
(CFB) and isocitrate dehydrogenase 2 (NADP+), soluble (IDH2) – with mastitis 296 
susceptibility [32]. In the present study, several of these genes (CTLA4, SOCS2, OSMR), 297 
along with some from the same family (FYB, C9, IDH1), were also found to be LPS-298 
inducible in BFxT sheep BMDMs and/or differentially expressed in the milk somatic cells of 299 
Churra and Assaf, indicating they are likely to be involved in protective immunity across 300 
sheep populations. The SNP marker located within the IDH1 gene corresponds to a missense 301 
mutation but further work is needed to verify if this is the actual causative mutation. For the 302 
OSMR and C9 genes, differences in the TFBS in the 1 kb upstream regions were also 303 
identified among dairy and meat sheep. The proto-oncogene c-Rel – whose binding site was 304 
identified in the sequence upstream of C9 in dairy sheep – is a member of the nuclear factor 305 
kappa b (NFkb) family of transcription factors, whose activity has been previously related 306 
with mastitis resistance in dairy cattle [39]. However, further studies are needed to confirm if 307 
these promoter variants are functionally important. Moreover, most of the candidate genes for 308 
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mastitis resistance identified in the present study were previously reported to control mastitis 309 
resistance in dairy cattle, including CTLA4 [40], IDH1, OSMR, C6, C7 and C9, mitogen-310 
responsive phosphoprotein, homolog 2 (DAB2), caspase recruitment domain family, member 311 
6 (CARD6) [41, 42], and prostaglandin E receptor 4 (PTGER4) [43, 44]. This suggests that 312 
dairy sheep and cattle may partially share common underlying mechanisms and genes critical 313 
to a successful host response to mastitis infection. 314 
Based upon their transcriptional profiles and association with SCC, novel functional 315 
candidates for mastitis resistance were identified in the present study. These include inducible 316 
T-cell co-stimulator (ICOS), leukaemia inhibitory factor receptor A (LIFR), plexin C1 317 
(PLXNC1) and chromodomain-helicase-DNA-binding protein 1 (CHD1). The proteins 318 
encoded by these genes have been previously associated with multiple diseases in humans 319 
[45-49] and other species [50]. The clear enrichment of LPS-inducible genes in the QTL 320 
regions also offers the possibility of using this assay to identify both cis- and trans-acting 321 
eQTLs that are relevant to mastitis, similar to a previous study of human monocytes that 322 
highlighted loci associated with inflammatory disease susceptibility [22]. The fact that the set 323 
of LPS-inducible genes overlaps with genes whose level of expression was correlated with 324 
SCC attests to the utility of the assay as a model for mastitis in sheep. However, further 325 
studies are needed to confirm the present results and identify the actual causative genes and 326 
mutations. 327 
Conclusion 328 
Both innate and adaptive immune responses, along with the induction of specific metabolic 329 
genes, are likely to be involved in the genomic architecture of sheep resistance to mastitis. 330 
All the mastitis traits analysed in the present study exhibited heritable variation, suggesting 331 
that selection and management programmes aiming at enhancing mastitis resistance are 332 
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feasible. Genetic selection against mastitis may be achieved using primarily indirect 333 
(indicator) traits such as SCC, CMT and TVC but a combination of both clinical mastitis and 334 
indicator traits would be preferable. A possible implementation scenario might entail marker-335 
assisted selection based on validated selectable markers and the candidate genes identified in 336 
the present study. Another option would be the implementation of genomic prediction and 337 
selection schemes across different dairy sheep breeds sharing common QTLs for mastitis 338 
resistance, leading to enhanced reference population size and greater accuracy. 339 
 340 
Methods 341 
Ethics statement  342 
The study was approved by the Ethics and Research Committee of the Faculty of Veterinary 343 
Medicine, Aristotle University of Thessaloniki, Greece. Permits for access and use of the 344 
commercial farms were granted by the individual farm owners, who were members of the 345 
Chios Sheep Breeders’ Cooperative “Macedonia”. During sampling, animals were handled by 346 
qualified veterinarians. Permission to qualified veterinarians to perform milk and blood 347 
sampling was granted by the National (Greek) Legislature for the Veterinary Profession, No. 348 
344/29-12-2000. For the ovine transcriptional atlas study approval was obtained from The 349 
Roslin Institute’s and the University of Edinburgh’s Protocols and Ethics Committees. All 350 
animal work was carried out under the regulations of the Animals (Scientific Procedures) Act 351 
1986. 352 
Principal component analysis 353 
A total of 23 Chios, 103 Lacaune, 120 Churra and 20 Sarda dairy sheep were analysed 354 
within the sheep HapMap project [15]. Genotyping and SNP quality control are detailed in 355 
Kijas et al. [20]. PCA was performed using PLINK v1.9 [51], which created an identity-by-356 
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state matrix for assessing the genetic differences among the four populations, and allowed 357 
the average genetic distance between Chios and each of the other three breeds to be 358 
estimated. 359 
Animals, sampling and phenotyping 360 
A total of 609 purebred Chios dairy ewes in the first or second lactation, raised in four 361 
commercial farms in Greece, were used. Presence or absence (0/1) of CM was recorded by an 362 
experienced veterinarian in monthly visits during the first five months of lactation. On the day 363 
of visit, two 50 ml milk samples were collected in the milking parlour under aseptic 364 
conditions for the measurement of three traits indirectly related with mastitis: CMT, SCC and 365 
TVC. CMT was scored on a scale from 0 to 4 [52], with high values indicating the presence 366 
of elevated SCC and, potentially, pathogens in milk; this test was performed with a 367 
commercial kit according to manufacturer’s instructions (Bovi-vet, Kruuse, Germany). SCC 368 
was measured with Fossomatic 360 (Foss Electric, Hillerød, Denmark) and expressed as the 369 
number of cells/ml of milk. TVC was measured with Bactoscan FC 50 (Foss Electric, 370 
Hillerød, Denmark) and expressed as the number of viable bacteria/ml of milk. In total, 2,436 371 
individual animal records were collected. Peripheral blood samples were collected from each 372 
ewe in 9 ml K2EDTA Vacutainer blood collection tubes (BD diagnostics) by jugular 373 
venepuncture for genomic DNA extraction.  374 
A total of 638 samples with a CMT score greater than or equal to 2 and/or at least 375 
500,000 somatic cells/ml milk (cut-off values selected on the basis of bibliographic evidence 376 
[53]), were further tested by selective culturing on MacConkey agar for Gram-negative 377 
bacteria, and on Mannitol Salt agar and Blood agar followed by Gram staining for Gram 378 
positive bacteria. The plates were incubated at approximately 37°C for 24 h. The next day, the 379 
plates were examined for bacterial growth.  380 
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Genetic Parameter Estimation 381 
The distributions of SCC and TVC records were skewed; therefore, records were naturally 382 
log-transformed in order to achieve normality of the respective distributions. Monthly animal 383 
records were analysed with the following mixed model to derive variance components and 384 
genetic parameters for the overall lactation; each trait was analysed separately: 385 
 )(epegWPbLageaYSFY ijkmnooo
n
mnnkjiijkmno 1
2
1
1  

  386 
Where: Y = record of ewe o in week of lactation (i.e. week post-lambing) m 387 
 µ = overall mean 388 
 F = fixed effect of flock i 389 
 YS = fixed effect of year-season of lambing j 390 
 α1 = linear regression on age at lambing (age) 391 
 L = fixed effect of lactation number k 392 
 W = fixed effect of week of lactation m 393 
 bn = fixed regression coefficient on week of lactation m (order n=2) 394 
 Pn = orthogonal polynomial of week of lactation m (order n=2) 395 
g = random additive genetic effect of ewe o, including pedigree genetic relationships 396 
among animals 397 
pe = random permanent environment effect of ewe o 398 
 e = random residual effect 399 
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A Logit function was fitted to the CM analysis to account for the binary nature (0/1) of 400 
the trait. For all traits, the fixed regression on week of lactation yielded a smoothed curve 401 
illustrating the trait progression throughout lactation. Heritability and repeatability estimates 402 
were derived from the variance components of the random effects for each trait. Residuals 403 
from these analyses were kept to be used as dependent variables in the ensuing genomic 404 
association studies aiming to assess the effect of SNPs on the respective traits expressed 405 
across the entire lactation. Subsequently, bivariate analyses were conducted with the above 406 
model to estimate genetic and phenotypic correlations among traits. 407 
In separate analyses of SCC, CMT and TVC, second-order polynomial functions of 408 
week of lactation were fitted to the additive genetic and permanent environment effects of 409 
model (1), resulting in separate variance component and genetic parameter estimates by week 410 
of lactation. The latter were then combined to derive average heritability and repeatability 411 
estimates for early (weeks of lactation 1-7), mid (weeks 8-17) and late (weeks 18-23) 412 
lactation. The corresponding residuals were also kept as input variables to the genomic 413 
association studies aiming to assess the impact of SNPs on traits expressed in different stages 414 
of lactation. These analyses were not possible with the Logit function fitted to the analysis of 415 
binary CM. Therefore, a linear model was fitted to this trait in order to derive residuals by 416 
lactation stage for the genomic association analysis. All mixed model analyses were 417 
conducted with ASReml v4.0  [54]. 418 
DNA extraction 419 
Genomic DNA for all samples was extracted from blood buffy coat using a modified protocol 420 
(Modified Blood) as described by Psifidi et al [55]. 421 
Genomic association analysis 422 
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All animals were genotyped with a customized 960-SNP DNA array containing SNPs located 423 
in seven previously identified QTL regions for mastitis resistance on chromosomes 2, 3, 5, 12, 424 
16 and 19. Details of the SNPs comprising the DNA array are presented in Additional File 14: 425 
Table S9. SNP genotypes were subjected to quality control measures using the following 426 
thresholds: minor allele frequency < 0.05, call rate < 95% and Hardy-Weinberg equilibrium P 427 
< 10
-6
. After quality control, 710 SNP markers remained for further analysis. SNP locations 428 
were obtained from the Oar v3.1 assembly using the Ensembl genome browser 429 
(www.ensembl.org). To account for possible population stratification, a genomic relationship 430 
matrix was generated including all individual animals. This genomic relationship matrix was 431 
converted to a distance matrix that was used to carry out classical MDS analysis with the R 432 
package GenABEL [56]. Individual ewe phenotypes were adjusted for the same fixed effects 433 
included in model (1). Phenotypes pertained to the entire course of lactation as well as to 434 
different stages (early, mid, late) of lactation as explained above. In all cases, GEMMA 435 
v0.94.1 [57] was used to run the genomic association analyses of adjusted phenotypes based 436 
on a mixed model that included the genomic relationship matrix among individual ewes as a 437 
random effect. After Bonferroni correction for multiple testing, the P≤ 0.05 significance 438 
threshold was set at P ≤ 7.04 x 10-5 and a suggestive significance threshold (accounting for 439 
one false positive per genome scan) was set at P ≤ 1.41 x 10-3. 440 
LD among significant SNPs was calculated as an r
2
 value using PLINK v1.9 [51] in 441 
order to evaluate the extent of LD and identify candidate regions potentially containing causal 442 
mutations for mastitis resistance. Furthermore, LD blocks in the regions where significant 443 
SNPs were found with GWAS were visualised using the software Haploview v4.2 [58] 444 
SNP locus effect confirmation 445 
Individual markers found to be significant in the previous step were further examined with a 446 
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mixed model that included the fixed effects of model (1), the fixed effect of the corresponding 447 
SNP locus genotype and the random effect of the animal. Additive (a) and dominance (d) 448 
effects, and the proportion of additive genetic variance (PVA) and total phenotypic variance 449 
(PVP) due to each SNP locus were calculated as follows: 450 
a = (AA-BB)/2 451 
d = AB-((AA+BB)/2)  452 
PVA = (2pq (a+d (q-p))
2
)/VA  453 
PVP = (2pq (a+d (q-p))
2
)/VP 454 
where AA, BB and AB were the predicted trait values of the respective genotypic classes, p 455 
and q were the allelic frequencies of A and B at the SNP locus, and VA and VP were the 456 
additive genetic and total phenotypic variance of the trait. The latter were estimated with 457 
model (1). All analyses were run with ASReml v4.0 [54]. 458 
Annotation of the SNP markers and the QTL candidate regions 459 
For sheep assembly Oar v3.1, the Ensembl Variant Effect Predictor (VEP) 460 
(http://www.ensembl.org/Tools/VEP) and BioMart data mining tools 461 
(http://www.ensembl.org/biomart/martview/) were used to map and annotate the significant 462 
SNP markers derived with the genomic association analysis on the reference genome, and to 463 
locate genes in the corresponding candidate regions for mastitis resistance. 464 
Pathway and functional annotation clustering analysis  465 
Gene lists in the candidate regions for mastitis resistance were analysed using the Ingenuity 466 
Pathway Analysis (IPA) programme (www.ingenuity.com) in order to identify canonical 467 
pathways and gene networks constructed by the products of these genes. IPA constructs 468 
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multiple possible upstream regulators, pathways and networks serving as hypotheses for the 469 
biological mechanism underlying the trait. This analysis uses data from a large-scale causal 470 
network derived from the Ingenuity Knowledge Base. IPA then infers the most suitable 471 
pathways and networks based on their statistical significance, thereby setting a threshold 472 
above which the pathways are significant. 473 
Gene lists were also analysed against an Ovis aries background using the Database for 474 
Annotation, Visualization and Integrated Discovery (DAVID v6.7) [59]. For each gene, we 475 
determined its GO terms and performed functional annotation clustering analysis to detect 476 
possible enrichment. The ES calculated with DAVID is a modified Fisher’s exact test P-477 
value, with increasing ES (>1) reflecting over-representation of that functional category. 478 
Gene expression analysis 479 
Expression levels of each gene located within candidate regions for a mastitis trait were 480 
obtained from a transcriptomic atlas of 406 RNA-seq libraries, representing all major organ 481 
systems; the atlas was based on a BFxT sheep cross [23] and also included 83 libraries from a 482 
Texel sheep trio (ewe, ram and lamb) as described in Jiang et al. [60]. In the present study, 483 
we were specifically interested in mammary gland, immune-related tissues and cell lines. 484 
Therefore, we extracted data pertaining to the haemolymph nodes, mesenteric, popliteal, 485 
prescapular and submandibular lymph nodes, peripheral blood mononuclear cells, blood 486 
leukocytes, monocyte-derived macrophages, alveolar macrophages, tonsils, and mammary 487 
glands. The atlas also contained data from sheep BMDMs at different time points (0h, 2h, 4h, 488 
7h and 24h) after LPS treatment [23], which we used here as a model for mastitis, to identify 489 
candidate genes that are likely involved in the inflammatory response to bacterial infection. 490 
LPS stimulation mimics Gram-negative pathogens, which accounted for 12% of the mastitis 491 
incidence in the Chios sheep in the present study. LPS stimulation also provides a general 492 
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model for toll-like receptor (TLR) signalling and inflammatory pathology which causes 493 
morbidity and production losses associated with mastitis. To supplement this dataset, we  494 
obtained expression levels from a previous transcriptomic study of the milk somatic cells of 495 
two Spanish dairy sheep breeds, Churra and Assaf [27]. The sheep used in this study had also 496 
been phenotyped for SCC and milk yield [26]; these records were made available to the 497 
present study. 498 
To generate RNA for library preparation, BMDMs were differentiated for 7 days in 499 
recombinant human colony stimulating factor and treated with LPS (Salmonella minnesota 500 
Re 595 (L9764; Sigma-Aldrich)) at a concentration of 100ng/ml.  Salmonella is a TLR4 501 
agonist; Staphylococcus aureus, which is the main cause of mastitis in dairy sheep, is known 502 
to activate both TLR2 and TLR4 [61] in cattle. BMDMs were harvested into Trizol 503 
(Thermofisher) at each different time point post LPS treatment in preparation for RNA 504 
extraction. For all samples in the transcriptomic atlas, RNA was extracted using Trizol 505 
(Thermofisher) followed by column purification and DNAse treatment using the RNeasy 506 
Mini Kit (Qiagen). The resultant RNA was checked for quality using the Agilent Tapestation 507 
2200, and all samples were of high quality with RNA Integrity Numbers (RIN
e
) greater than 508 
9. All RNA-Seq libraries from the sheep transcriptional atlas included in this study were 509 
TruSeq stranded mRNA libraries (125bp paired-end). Libraries were prepared by Edinburgh 510 
Genomics (https://genomics.ed.ac.uk/) using the TruSeq mRNA Library Preparation kit 511 
(Illumina) and sequenced on the Illumina HiSeq v2500 at a depth of > 25 million reads per 512 
sample. 513 
Expression levels for all samples from both the transcriptomic atlas and the milk 514 
somatic cell transcriptome were estimated using Kallisto v0.42.4 [62]. Rather than aligning 515 
RNA-seq reads to a reference genome, reconstructing transcripts from these alignments and 516 
then quantifying expression as a function of the reads aligned (the conventional means of 517 
 P
ag
e2
3
 
RNA-seq processing), Kallisto employs a ‘lightweight’ algorithm, which first builds an index 518 
of k-mers from a known transcriptome: the Ovis aries v3.1 cDNAs 519 
(ftp://ftp.ensembl.org/pub/release-520 
83/fasta/ovis_aries/cdna/Ovis_aries.Oar_v3.1.cdna.all.fa.gz, obtained from Ensembl v84 521 
[63]; n = 23,113 transcripts [22,823 protein-coding, 247 pseudogenes, 43 processed 522 
pseudogenes]). Expression level is then estimated directly (i.e., in an alignment-free manner) 523 
by quantifying exact matches between reads and k-mers. Expression is reported per transcript 524 
as the number of transcripts per million, and is summarised to the gene-level as described 525 
previously [64].  526 
Differential expression analysis was run on the LPS time series data using the Kallisto 527 
output with the R/Bioconductor package ‘Sleuth’. Heatmaps were drawn using the heatmap.2 528 
function from the R package gplots v3.0.1. Additional differential expression analyses were 529 
conducted between sheep with high, moderate and low levels of SCC, after adjusting for 530 
breed (Churra and Assaf). Relevant data for this study are described by Suarez-Vega et al. 531 
[22]. Least square mean pairwise comparisons between SCC levels were conducted. Tukey’s 532 
HSD post-hoc test adjustment was applied at a significance level of 0.05. 533 
Furthermore, the effect of the expression level of each gene (located within a 534 
candidate region for mastitis resistance) on SCC and milk yield was assessed using the 535 
following linear model: 536 
)2(ijjiij egBY    537 
where Y = record of ewe (SCC or milk yield across lactation), µ = overall mean, B = fixed 538 
effect of breed i, g = fixed effect of the mean expression of gene j, e = random residual effect. 539 
The significance threshold in this analysis was set at 0.05. Since genes were located within 5 540 
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QTL regions, an FDR adjustment for multiple testing was applied and the significance 541 
threshold was subsequently re-set to P ≤ 0.0125. The analyses were conducted with ASReml 542 
v4.0 [36]. 543 
Transcription factor binding site analysis  544 
In order to identify whether differences in TFBS are associated with differences in 545 
expression level of the genes found in the candidate regions for mastitis resistance, we 546 
extracted and compared the corresponding 1kb upstream sequence in all genes from both 547 
meat and dairy sheep. Specifically, we extracted the sequences from the six sheep used to 548 
create the BFxT transcriptomic atlas and six sheep sequenced as part of the Sheep HapMap 549 
Project [15] (two Churra, two Lacaune [one dairy and one meat] and two Sakiz dairy sheep; 550 
NCBI Sequencing Read Archive (SRA) accession numbers SRR501848, SRR501909, 551 
SRR501850, SRR501851, SRR501843 and SRR501878, respectively; BioProject 552 
PRJNA160933). 553 
The six atlas sheep (BFxT) had been fully re-sequenced. Illumina Tru-Seq Nano 350 554 
gel-free libraries (125bp paired end) were prepared, for each sample, by Edinburgh 555 
Genomics (https://genomics.ed.ac.uk). The six libraries were run on one lane of the Illumina 556 
HiSeq2500 System to generate in total approximately 220M+220M reads resulting in a 10-557 
fold coverage per sample. Details of the re-sequencing methodology within the HapMap 558 
sheep project can be found in Kijas et al. [15]. In both cases, the 1kb upstream regions for 559 
each gene were extracted using BEDTools v2.25 [65]. These were then analysed using the 560 
MATCH algorithm within the TRANSFAC
®
 7.0 Suite, with default parameters, which 561 
predicts TFBS in DNA sequences using a library of positional weight matrices [35]. 562 
 563 
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Figure Legends 564 
Figure 1. Smoothed fixed curves of the mastitis traits studied in Chios sheep by week of 565 
lactation. Curves for milk somatic cell count (SCC), California mastitis test (CMT), total 566 
viable bacterial count in milk (TVC) and clinical mastitis occurrence (CM) are presented. 567 
Figure 2. Manhattan plots displaying the genomic association results of the mastitis 568 
traits studied in Chios sheep. Manhattan plots for milk somatic cell count (SCC) in early 569 
(A), late (B), and overall (C) lactation; for California mastitis test (CMT) in early (D), mid 570 
(E), late (F), and overall (G) lactation; for  total viable bacterial count in milk (TVC) in early 571 
(H), late (I),  and overall (J) lactation; for clinical mastitis occurrence (CM) in early (K), mid 572 
(L), late (M), and overall (N) lactation.  Chromosome location is plotted against -log10(P). 573 
Red and blue lines, respectively, are thresholds for significance post-Bonferroni correction 574 
(P<0.05) and for suggestive significance (accounting for one false positive per genome scan). 575 
No significant results were identified for TVC and SCC in mid lactation. 576 
Figure 3.  Pathway and network analysis using the IPA software.  (A) The most highly 577 
represented canonical pathways derived from genes located within the candidate regions for 578 
mastitis resistance in Chios sheep. The solid yellow line represents the significance threshold. 579 
The line joining squares represents the ratio of the genes represented within each pathway to 580 
the total number of genes in the pathway. (B) Two networks, both related to immunological 581 
disease, that illustrate the molecular interactions between the products of candidate genes 582 
selected from QTL regions for mastitis resistance in Chios sheep. Arrows with solid lines 583 
represent direct interactions and arrows with broken lines represent indirect interactions. 584 
Genes with white labels are those added to the IPA analysis because of their interaction with 585 
the target gene products. 586 
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Figure 4. Differential expression of genes located in the candidate regions for mastitis 587 
resistance post treatment with LPS. Each column represents gene expression level in sheep 588 
bone marrow-derived macrophages 0, 2, 4, 7 and 24 hours post treatment with LPS, 589 
respectively. Expression level is shown as (A) average TPM (transcripts per million) at the 5 590 
different time points, and (B) as log2 fold change in expression at 2, 4, 7 and 24 hours relative 591 
to expression at 0 hours. Significance thresholds indicated as: P < 0.05*, P < 0.01** and P < 592 
0.001***. 593 
Figure 5.  Differential expression of genes located in the candidate regions for mastitis 594 
resistance across individuals with low, medium and high milk somatic cell count. 595 
Expression in milk somatic cells is shown as average TPM (transcripts per million) across all 596 
experimental replicates. Significance values were estimated using Tukey’s HSD post hoc test 597 
(P<0.05*). 598 
 599 
Additional Files 600 
Additional File 1: Table S1. Location of identified QTL regions for mastitis resistance in 601 
Chios sheep (present study) as well as Lacaune, Churra and Sarda sheep from previous 602 
studies.  603 
Additional File 2: Figure S1. Principal component analysis results for Chios, Lacaune, 604 
Churra and Sarda sheep.  Red dots represent Chios (present study), green dots Churra, blue 605 
dots Lacaune and orange dots Sarda sheep (previous studies).  606 
Additional File 3: Table S2. Descriptive statistics of milk somatic cell count (SCC), 607 
California mastitis test (CMT) and total viable bacterial count in milk (TVC). 608 
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Additional File 4: Table S3. Genetic correlations among mastitis measures in different 609 
lactation stages in Chios sheep. 610 
Additional File 5: Figure S2. Q-Q plots displaying the genomic association results for 611 
the mastitis traits studied in Chios sheep. Q-Q plots for milk somatic cell count (SCC) in 612 
early (A), late (B) and overall (C) lactation; for California mastitis test (CMT)  in early (D), 613 
mid (E), late (F) and overall (G) lactation; for  total viable bacterial count in milk (TVC) in 614 
early (H), late (I) and overall (J) lactation; for clinical mastitis occurrence (CM) in early (K), 615 
mid (L), late (M) and overall (N) lactation; Observed P-values are plotted against the 616 
expected P-values for each trait. Q-Q plots are not presented for TVC and SCC in mid 617 
lactation since no significant results for these traits were identified.  618 
Additional File 6: Table S4. Linkage disequilibrium (LD) estimation (as r
2
) for the 619 
significant SNP markers identified in the genomic association analyses of mastitis 620 
resistance in Chios sheep. 621 
Additional File 7: Figure S3. Patterns of linkage disequilibrium (LD) for SNP markers 622 
associated significantly with mastitis resistance in Chios sheep. LD patterns are shown for 623 
chromosomes 2 (A), 3 (B), 5 (C), 16 (D) and 19 (E). LD blocks are marked with triangles. 624 
The significant markers are illustrated with a blue arrow. The candidate regions for mastitis 625 
resistance identified in previous studies and in Chios sheep (present study) are marked with 626 
dashed lines. The strongest LD signals are in red and the weakest in white. 627 
Additional File 8: Table S5. Genes located in the candidate genomic regions for mastitis 628 
resistance in Chios sheep. 629 
Additional File 9: Table S6. Annotation of SNPs identified to have a significant 630 
association with mastitis resistance traits.  631 
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Additional File 10: Table S7. Functional annotation clustering analysis of the genes 632 
located in the candidate regions for mastitis resistance.  633 
Additional File 11: Figure S. Expression level of genes, located in the mastitis resistance 634 
candidate regions, across both mammary glands and immune cell lines/tissues.  635 
Expression level is estimated as the mean TPM (transcripts per million) of all (5) 636 
experimental replicates and is represented here as a Z-score per cell line/tissue. Data is 637 
obtained from two transcriptomic atlases; one of Scottish Blackface x Texel (BFxT) sheep 638 
and one of Texel sheep. 639 
Additional File 12: Figure S5. Expression level of genes, located in the mastitis 640 
resistance candidate regions, as extracted from the Churra/Assaf milk somatic cell 641 
transcriptome analysis. Expression level is estimated as the mean TPM (transcripts per 642 
million) of all (5) experimental replicates and is represented here as a Z-score per individual 643 
animal. 644 
Additional File 13: Table S8. Transcription factor binding site analysis using the 645 
MATCH programme. 646 
Additional File 14: Table S9. List of SNP markers comprising the mastitis-specific 647 
custom-made array used in the genomic association analysis of Chios sheep.  648 
Additional File 15: Table S10. Expression levels of genes located in the candidate 649 
regions for mastitis resistance identified in Chios sheep. The gene expression levels 650 
presented here are across all the body tissues and cell lines, as extracted from the two (BFxT 651 
and Texel) sheep transcriptomic atlases. Details on the expression profile of each gene across 652 
the transcriptomic atlas are also provided. 653 
 654 
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Availability of supporting data 655 
The SNP information of the mastitis specific custom-made 960 SNP array is available in 656 
Additional File 15: Table S9. Expression levels for all studied genes in all tissues and cell 657 
lines as extracted from the two sheep transcriptomic atlases are presented in Additional File 658 
16: Table S10. In addition, all the expression data comprising the mini ovine (Texel) 659 
transcriptional atlas is available in the European Nucleotide Archive (ENA) under accession 660 
number PRJEB6169) and the data from the ovine (BFxT) transcriptional atlas has been 661 
submitted to the ENA under the accession number PRJEB19199. To supplement the data 662 
from these two transcriptomic atlas projects, we also obtain expression levels from a milk 663 
transcriptomic study of the milk somatic cells of two Spanish dairy sheep breeds, Churra and 664 
Assaf (NCBI BioProject ID PRJNA301615). 665 
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CHD1: chromodomain-helicase-DNA-binding protein 1 676 
CM: clinical mastitis occurrence 677 
CMT: California mastitis test 678 
CTLA4: cytotoxic T lymphocyte-associated protein 4 679 
DAB2: mitogen-responsive phosphoprotein, homolog 2 680 
DAVID: Database for Annotation, Visualization and Integrated Discovery  681 
Dst: pairwise genetic distance 682 
E. coli: Escherichia coli 683 
ES: enrichment score 684 
eQTL: expression quantitative trait loci 685 
FYN: FYN oncogene related to SRC  686 
GO: gene ontology 687 
ICOS: inducible T-cell co-stimulator 688 
IDH1: isocitrate dehydrogenase 1 (NADP+), soluble 689 
IDH2: isocitrate dehydrogenase 2 (NADP+), soluble 690 
IPA: Ingenuity Pathway Analysis  691 
LD: linkage disequilibrium 692 
LIFR: leukaemia inhibitory factor receptor A 693 
LPS: lipopolysaccharide 694 
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MDS: multidimensional scaling analysis 695 
OSMR: oncostatin M receptor 696 
PCA: principal component analysis 697 
PLXNC1: plexin C1   698 
PTGER4: prostaglandin E receptor 4 699 
QTL: quantitative trait locus 700 
S. aureus: Staphylococcus aureus 701 
SCC: milk somatic cell count 702 
SNP: single nucleotide polymorphism 703 
SOCS2: suppressor of cytokine signalling 2 704 
SRA: NCBI Sequencing Read Archive  705 
TFBS: Transcription factor binding site 706 
TVC: total viable bacterial count in milk 707 
VEP: Variant Effect Predictor  708 
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Tables 740 
Table 1. Heritability (h
2
) and repeatability (r) estimates for four mastitis traits studied in 741 
Chios sheep, by stage of lactation. 742 
Trait Parameter 
Early lactation 
(weeks 1-7) 
Mid lactation 
(weeks 8-17) 
Late lactation 
(weeks 18-23) 
Overall lactation 
(weeks 1-23) 
SCC h
2
 0.10 (0.05) 0.09 (0.05) 0.18 (0.05) 0.11 (0.05) 
 
r 0.55 (0.03) 0.54 (0.02) 0.66 (0.02) 0.58 (0.02) 
CMT h
2
 0.12 (0.06) 0.10 (0.05) 0.17 (0.06) 0.12 (0.06) 
 
r 0.60 (0.03) 0.59 (0.02) 0.68 (0.02) 0.62 (0.02) 
TVC h
2
 0.09 (0.05) 0.08 (0.04) 0.15 (0.05) 0.09 (0.05) 
 
r 0.28 (0.04) 0.27 (0.03) 0.34 (0.04) 0.33 (0.04) 
CM h
2
 NA NA NA 0.18 (0.10) 
 
r NA NA NA 0.35 (0.06) 
SCC: log-transformed milk somatic cell count; CMT: California mastitis test; TVC: log-
transformed total viable bacterial count in milk; CM: clinical mastitis occurrence (0/1, analysed 
with a logit function); NA: non-applicable; standard errors in parentheses. 
  743 
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Table 2. Estimates of genetic (above diagonal) and phenotypic (below diagonal) correlations 744 
between the mastitis traits studied in Chios sheep (overall lactation). 745 
 746 
747 
 748 
  749 
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Table 3. List of SNPs associated with clinical mastitis occurrence and three mastitis indicator traits in Chios sheep. 750 
Trait Lactation stage SNP *Chr(position) 
GAS a d 
PVA PVP p q 
P-value (P-value) (P-value) 
SCC 
early 
oar3_OAR19_27830713 19(27830713) 5.54E-04 -0.39(0.00) -0.09(0.42) 0.36 0.04 0.62 0.38 
(weeks 1-7) 
  oar3_OAR19_27397476 19(27397476) 7.74E-04 -0.41(0.03) 0.32(0.15) 0.38 0.04 0.34 0.66 
  OAR19_29193780 19(27558690) 8.00E-04 0.46(0.00) 0.30(0.04) 0.4 0.04 0.75 0.25 
  OAR19_29776311 19(28134366) 1.28E-03 0.33(0.09) 0.09(0.26) 0.12 0.01 0.87 0.13 
late 
oar3_OAR2_208650955 2(208650955) 2.31E-05 -0.24(0.07) -0.52(0.00) 0.19 0.01 0.71 0.29 
(weeks 18-23) 
  oar3_OAR2_206805418 2(206805418) 8.25E-05 -0.27(0.00) 0.45(0.13) 0.07 0 0.99 0.01 
  OAR2_219641896 2(207420807) 1.65E-04 -0.14(0.46) 0.22(0.25) 0.01 0 0.83 0.17 
  OAR2_216496832 2(204569747) 1.89E-04 -0.22(0.04) 0.01(0.91) 0.11 0.01 0.38 0.62 
  oar3_OAR2_208711940 2(208711940) 6.73E-04 0.11(0.41) -0.68(0.00) 0.18 0 0.19 0.81 
  oar3_OAR2_207141059 2(207141059) 9.52E-04 -0.14(0.00) -0.84(0.00) 0.14 0 0.96 0.04 
  oar3_OAR2_205201880 2(205201880) 1.44E-03 -0.28(0.01) 0.03(0.79) 0.08 0.01 0.64 0.36 
  oar3_OAR2_204683757 2(204683757) 1.51E-03 -0.20(0.04) 0.09(0.42) 0.04 0.01 0.49 0.51 
  oar3_OAR19_27100147 19(27100147) 2.75E-05 0.52(0.02) 0.63(0.00) 0.39 0.03 0.85 0.15 
overall OAR16_38842323 16(35633299) 1.69E-03 -0.18(0.01) 0.12(0.13) 0.04 0 0.8 0.2 
(weeks 1-23) 
oar3_OAR19_27830713 19(27830713) 1.45E-03 -0.21(0.01) 0.15(0.16) 0.09 0.01 0.62 0.38 
  
CMT 
early oar3_OAR19_27397476 19(27397476) 3.67E-04 -0.36(0.00) 0.07(0.50) 0.28 0.03 0.34 0.66 
(weeks 1-7) oar3_OAR19_27100147 19(27100147) 3.93E-04 0.57(0.06) 0.33(0.31) 0.39 0.05 0.85 0.15 
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  OAR19_29776311 19(28134366) 4.78E-04 0.37(0.05) 0.10(0.60) 0.15 0.02 0.87 0.13 
  OAR19_29193780 19(27558690) 9.22E-04 0.42(0.00) 0.21(0.12) 0.31 0.04 0.75 0.25 
  oar3_OAR19_27723161 19(27723161) 1.18E-03 0.34(0.04) 0.11(0.54) 0.14 0.02 0.85 0.15 
mid 
oar3_OAR19_27830713 19(27830713) 4.31E-04 -0.20(0.01) 0.09(0.35) 0.11 0.01 0.62 0.38 
(weeks 8-17) 
  OAR19_27896777 19(26442150) 6.20E-04 0.61(0.01) 0.15(0.56) 0.19 0.04 0.91 0.09 
  
oar3_OAR19_27264253 19(27264253) 9.35E-04 0.20(0.01) -0.02(0.79) 0.11 0.01 0.59 0.41 
late oar3_OAR2_206805418 2(206805418) 9.71E-04 -0.19(0.00) 0.29(0.28) 0.03 0 0.99 0.01 
(weeks 18-23) oar3_OAR3_130101204 3(130101204) 1.18E-03 0.12(0.00) 0.14(0.15) 0.01 0 0.9 0.1 
  OAR3_130096528.3SR 3(130096528) 1.32E-03 0.93(0.17) 0.98(0.16) 0.43 0.07 0.9 0.1 
 
oar3_OAR16_35319166 16(35319166) 4.60E-04 -0.22(0.12) 0.26(0.16) 0.04 0.01 0.81 0.19 
  OAR16_37125504 16(34187287) 1.21E-03 -0.69(0.02) -0.38(0.23) 0.24 0.04 0.89 0.11 
  oar3_OAR19_27100147 19(27100147) 1.79E-05 0.63(0.00) 0.79(0.00) 0.27 0.05 0.85 0.15 
  oar3_OAR19_26711220 19(26711220) 7.13E-04 0.08(0.00) -0.03(0.74) 0.01 0 0.93 0.07 
  oar3_OAR19_27830713 19(27830713) 1.16E-03 -0.20(0.01) 0.09(0.35) 0.05 0.01 0.62 0.38 
  OAR16_37125504 16(34187287) 1.21E-03 -0.69(0.02) -0.38(0.23) 0.24 0.04 0.89 0.11 
overall 
OAR16_37125504 16(34187287) 1.08E-03 -0.22(0.26) 0.12(0.56) 0.04 0.01 0.89 0.11 
(weeks 1-23) 
  
oar3_OAR19_27100147 19(27100147) 1.09E-03 0.36(0.03) 0.42(0.01) 0.51 0.02 0.85 0.15 
  oar3_OAR19_27830713 19(27830713) 1.16E-03 -0.18(0.00) 0.09(0.21) 0.07 0.01 0.62 0.38 
  
oar3_OAR19_27830713 19(27830713) 8.81E-04 -0.27(0.00) 0.08(0.37) 0.2 0.04 0.62 0.38 
TVC early OAR2_219801849 2(207575434) 5.81E-09 0.27(0.00) -0.23(0.03) 0.33 0.02 0.25  0.75 
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(weeks 1-7)  
late OAR2_219838408_X 2(207609417) 1.49E-08 0.22(0.03) -0.17(0.11) 0.22 0.02 0.26 0.74 
(weeks 18-23) OAR2_219641896 2(207420807) 1.26E-06 -0.15(0.27) -0.08(0.59) 0.07 0.01 0.83 0.17 
  oar3_OAR2_209240636 2(209240636) 2.85E-06 -0.19(0.51) -0.32(0.09) 0.05 0 0.93 0.07 
  oar3_OAR2_208650955 2(208650955) 2.26E-05 -0.12(0.18) -0.32(0.00) 0.07 0 0.71 0.29 
  oar3_OAR2_206805418 2(206805418) 4.11E-04 -0.15(0.00) 0.28(0.19) 0.03 0 0.99 0.01 
  OAR2_220844191 2(208597501) 4.81E-04 -0.10(0.22) -0.16(0.10) 0.05 0 0.69 0.31 
  
oar3_OAR2_206036682 2(206036682) 1.24E-03 -0.49(0.00) -0.50(0.00) 0.12 0.01 0.84 0.16 
overall OAR16_38842323 16(35633299) 1.27E-03 0.05(0.00) -0.01(0.84) 0.06 0 0.8 0.2 
(weeks 1-23) OAR16_37125504 16(34187287) 1.32E-03 -0.30(0.01) -0.13(0.29) 0.15 0.01 0.89 0.11 
  OAR19_27896777 19(26442150) 9.83E-04 0.16(0.16) -0.03(0.79) 0.07 0 0.91 0.09 
CM 
  OAR16_39143709 16(35930429) 6.98E-06 -1.72(0.36) 0.41(0.52) 0.25 0.05 0.54 0.46 
early OAR16_37226202 16(34279856) 4.16E-04 2.04(0.02) -0.80(0.39) 0.28 0.05 0.51 0.49 
(weeks 1-7) s74559 16(35801129) 4.41E-04 3.50(0.53) 2.81(0.61) 0.33 0.02 0.58 0.42 
  OAR16_37419505 16(34392335) 1.21E-03 -3.27(0.06) 1.74(0.16) 0.19 0.05 0.62 0.38 
  OAR16_37539041 16(34550197) 1.76E-03 1.60(0.01) -1.17(0.13) 0.26 0.05 0.39 0.61 
  oar3_OAR19_28110151 19(28110151) 6.23E-06 0.98(0.04) 0.74(0.12) 0.25 0.05 0.86 0.14 
  OAR19_29776311 19(28134366) 5.92E-05 1.02(0.05) 0.88(0.13) 0.25 0.04 0.87 0.13 
  OAR19_29193780 19(27558690) 4.95E-04 3.02(0.76) 2.66(0.79) 0.21 0.04 0.75 0.25 
  
oar3_OAR19_27018360 19(27018360) 8.26E-04 -1.11(0.05) 0.95(0.12) 0.26 0.05 0.46 0.54 
  
OAR5_104431404 5(95881956) 1.18E-06 0.82(0.00) 0.29(0.39) 0.35 0.06 0.6 0.4 
mid 
(weeks 8-17) oar3_OAR5_96114753 5(96114753) 8.66E-06 0.87(0.00) 0.41(0.25) 0.39 0.07 0.59 0.41 
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  OAR5_104389335_X 5(95841910) 2.28E-05 1.02(0.02) -1.01(0.06) 0.27 0.09 0.64 0.36 
  oar3_OAR5_96077046 5(96077046) 1.08E-04 0.59(0.03) 0.89(0.05) 0.12 0.03 0.41 0.59 
  oar3_OAR5_96062963 5(96062963) 1.07E-03 0.44(0.07) -0.22(0.14) 0.12 0.02 0.43 0.57 
  OAR16_37226202 16(34279856) 1.26E-03 2.02(0.02) 1.27(0.03) 0.21 0.04 0.51 0.49 
  OAR16_37539041 16(34550197) 1.94E-03 1.60(0.01) -
1.17(0.13) 
0.26 0.05 0.39 0.61 
  oar3_OAR19_26565985 19(26565985) 5.65E-04 -0.70(0.04) 0.32(0.48) 0.25 0.05 0.52 0.48 
  oar3_OAR19_26808003 19(268080030 6.95E-04 -0.58(0.05) -0.07(0.97) 0.14 0.02 0.74 0.26 
  OAR19_29482474 19(27864985) 1.30E-03 -3.49(0.86) -
3.33(0.87) 
0.23 0.04 0.1 0.9 
late oar3_OAR5_96114753 5(96114753) 1.81E-03 1.00(0.03) 0.81(0.10) 0.42 0.08 0.59 0.41 
  OAR5_104431404 5(95881956) 2.89E-04 0.98(0.03) 0.71(0.15) 0.4 0.07 0.6 0.4 
(weeks 18-23) OAR5_104389335_X 5(95841910) 9.99E-04 0.47(0.04) 0.66(0.17) 0.21 0.02 0.64 0.36 
  oar3_OAR5_96114753 5(96114753) 1.14E-03 0.62(0.01) 0.32(0.25) 0.24 0.04 0.59 0.41 
  OAR19_29776311 19(28134366) 1.08E-03 1.08(0.00) 1.07(0.01) 0.28 0.05 0.87 0.13 
  oar3_OAR19_27264253 19(27264253) 1.31E-03 1.00(0.03) 0.23(0.64) 0.42 0.08 0.59 0.41 
  oar3_OAR19_28110151 19(28110151) 1.53E-04 0.98(0.05) 0.74(0.21) 0.25 0.05 0.86 0.14 
  oar3_OAR19_26565985 19(26565985) 5.21E-04 -0.42(0.06) -0.06(0.82) 0.1 0.02 0.52 0.48 
  OAR19_29193780 19(27558690) 1.35E-03 0.56(0.10) 0.08(0.82) 0.15 0.02 0.75 0.25 
  
oar3_OAR2_207141059 2(207141059) 1.25E-03 -0.24(0.00) -1.95(0.01) 0.1 0 0.96 0.04 
overall 
(weeks 1-23) oar3_OAR19_27264253 19(2726253) 1.35E-03 0.88(0.00) 0.11(0.71) 0.36 0.07 0.59 0.41 
SCC : log-transformed milk somatic cell counts ; CMT: California mastitis Test ; TVC: total viable bacterial count in milk ; CM: occurrence of clinical mastitis ;* Chr(position) is 
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based on the Oar v3.1 assembly; GAS P–value: P-value from genomic association study  (genome-wide significant in bold, suggestive significance otherwise); a: additive allele 
substitution effect ; d: dominance effect; PVA: proportion of the genetic variance explained by the SNP; PVP: proportion of the phenotypic variance explained by the SNP; p and q 
allelic frequencies. No significant associations were identified for TVC and SCC in mid lactation. 
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Table 4.  Selected candidate genes for mastitis resistance. 755 
Gene 
Symbol 
Gene name Genomic 
location 
Functions 
CTLA4 Cytotoxic T-
lymphocyte-
associated 
2: 204777523- 
204784522 
Inhibitory receptor acting as a major negative regulator of T-cell responses 
[66]. 
 protein 4  
ICOS Inducible T-cell 
co-stimulator 
2: 204851429- 
204873693 
Enhances all basic T-cell responses to a foreign antigen, namely 
proliferation, lymphokine secretion, the upregulation of molecules that 
mediate cell-cell interactions, and antibody secretion by B-cells [67]. 
IDH1 Isocitrate 
dehydrogenase 1 
(NADP+), 
2:209236699-
209259307 
Isocitrate dehydrogenases catalyse the oxidative decarboxylation of isocitrate 
to 2-oxoglutarate; IDH1 also indirectly participates in mitigating oxidative 
damage and in the regulation of glucose-induced insulin secretion [68]. 
 Soluble   
SOCS2 Suppressor of 
cytokine signalling 
2 
3:129720516-
129722508 
A member of the suppressor of cytokine signalling (SOCS) family. SOCS 
family members are cytokine-inducible negative regulators of cytokine 
receptor signalling via the Janus kinase/signal transducer and activation of 
transcription pathway (the JAK/STAT pathway) [69]. The protein encoded 
by this gene interacts with the cytoplasmic domain of insulin-like growth 
factor-1 receptor (IGF1R) and is thought to be involved in the regulation of 
IGF1R mediated cell signalling [70]. 
PLXNC1 Plexin C1 3:130271380-
130424374 
This gene encodes a member of the plexin family. Plexins are transmembrane 
receptors for semaphorins, a large family of proteins that regulate axon 
guidance, cell motility and migration, and the immune response [71]. 
CHD1 Chromodomain-
helicase-DNA-
binding 
5:95366866-
95559633 
This gene encodes a protein that has been implicated in the regulation of 
transcription [72]. 
 protein 1   
C6 Complement 
component 6 
16:33267815- 
33338265 Constituents of the membrane attack complex, which plays a key role in the 
innate and adaptive immune response by forming pores in the plasma 
membrane of target cells [73]. 
 
C7 Complement 
component 7 
16:33481056- 
33542035 
C9 Complement 16:35014734- 
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component 9 35075088 
PTGER4 Prostaglandin E 
receptor 4 
16:33690480- 
33707155 
This receptor can activate T-cell factor signalling, mediate PGE2 induced 
expression of early growth response 1 (EGR1), regulate the level and 
stability of cyclooxygenase-2 mRNA, and lead to the phosphorylation of 
glycogen synthase kinase-3 [74]. 
    
DAB2 Dab, mitogen-
responsive  
phosphoprotein, 
homolog 2 
16:34976596-
34998498 
Adapter protein that functions as a clathrin-associated sorting protein, 
required for the clathrin-mediated endocytosis of selected cargo proteins. 
Mediates the activation of transforming growth factor beta (TFG-beta)-
stimulated c-Jun N-terminal kinases. May inhibit the canonical Wnt/beta-
catenin signalling pathway. Plays a role in the colony stimulating factor 1 
(CSF-1) signal transduction pathway. May also act as a tumour suppressor 
[75-77]. 
   
FYB FYN-binding 
protein 
16:35170143-
35269324 
The protein encoded by this gene is an adapter for the FYN protein and 
lymphocyte cytosolic protein 2 signalling cascades in T-cells. The encoded 
protein is involved in platelet activation and controls the expression of 
interleukin-2; it may also play a role in linking T-cell signalling to 
remodelling of the actin cytoskeleton [78]. 
OSMR Oncostatin M 
receptor 
16:35426282-
35474718 
Oncostatin M is a secreted cytokine involved in homeostasis and in diseases 
involving chronic inflammation. It is a member of the gp130 family of 
cytokines that have pleiotropic functions in differentiation and cell 
proliferation, as well as being involved in hematopoietic, immunologic, and 
inflammatory networks [79]. 
CARD6 Caspase 
Recruitment 
Domain 
16:33567396-
33580406 
CARD6 encodes a microtubule-associated protein that has been shown to 
interact with receptor-interacting protein kinases and to positively modulate 
signal transduction pathways converging on activation of the inducible 
transcription factor nuclear factor kB (NF-kB). It has a role in facilitating 
apoptosis [80, 81]. 
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